| Radiofrequency Ablation of Papillary Thyroid Microcarcinoma (NCT05132205) | Johns Hopkins University | 2021-12-17 |
| Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer. (NCT05752669) | Istituto Auxologico Italiano | 2021-09-15 |
| Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer (NCT04948437) | National Taiwan University Hospital | 2021-08-19 |
| Targeted Therapy to Increase RAI Uptake in Metastatic DTC (NCT05024929) | Children's Hospital of Philadelphia | 2021-07-16 |
| A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC (NCT05545852) | Nanfang Hospital, Southern Medical University | 2021-06-01 |
| A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors (NCT04731467) | Famewave Ltd. | 2021-03-19 |
| Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer (NCT04624477) | University Health Network, Toronto | 2021-02-03 |
| Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma (NCT04664413) | University of Salerno | 2021-02-01 |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer (NCT04544111) | Memorial Sloan Kettering Cancer Center | 2020-09-02 |
| The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma (NCT04076514) | Assiut University | 2020-09-01 |
| Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation (NCT04129411) | Mayo Clinic | 2020-06-15 |
| Papillary Thyroid Cancer and Central Lymp Node Dissection (NCT05873283) | Başakşehir Çam & Sakura City Hospital | 2020-06-12 |
| Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma (NCT04354324) | Zhujiang Hospital | 2020-04-20 |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (NCT03899792) | Eli Lilly and Company | 2019-06-13 |
| A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. (NCT03469011) | AHS Cancer Control Alberta | 2018-09-18 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer (NCT03630120) | H. Lee Moffitt Cancer Center and Research Institute | 2018-08-06 |
| Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging (NCT03470259) | University Medical Center Groningen | 2018-06-20 |
| Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma (NCT03889769) | University of Cagliari | 2016-12-20 |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |
| Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer (NCT02442661) | University of Colorado, Denver | 2015-04-01 |
| More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated (NCT06439745) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2014-09-01 |
| Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer (NCT02178345) | Memorial Sloan Kettering Cancer Center | 2014-06-24 |
| Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy (NCT02140476) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2014-05-01 |
| Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma (NCT01974284) | Yale University | 2014-03-01 |
| Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma (NCT06325787) | Chinese PLA General Hospital | 2013-05-01 |
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer (NCT01723202) | Bhavana Konda | 2012-11-07 |
| Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer (NCT01502410) | National Cancer Institute (NCI) | 2012-01-01 |
| Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment (NCT01441154) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-09-20 |
| CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer (NCT03359668) | University Health Network, Toronto | 2011-04-28 |
| Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid (NCT00984191) | Chulalongkorn University | 2010-03-01 |
| Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (NCT00668811) | Medstar Health Research Institute | 2008-04-01 |
| Study of XL281 in Adults With Solid Tumors (NCT00451880) | Exelixis | 2007-02-01 |
| The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience (NCT04500925) | Tel-Aviv Sourasky Medical Center | 2006-01-01 |
| Prophylactic Central Neck Dissection for Papillary Thyroid Cancer (NCT01510002) | Jagiellonian University | 1993-01-01 |
| Studies on Tumors of the Thyroid (NCT00001160) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1977-06-01 |
| Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014 (NCT03623516) | CHU de Reims | 1975-01-01 |
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company | |